Analysis of risk factors of diabetes peripheral neuropathy in type 2 diabetes mellitus and nursing intervention

Li,Zhifang; Lei,Xianlian; Xu,Bing; Wang,Suyun; Gao,Tiantian; Lv,Hongmei

doi:10.3892/etm.2020.9257

Analysis of risk factors of diabetes peripheral neuropathy in type 2 diabetes mellitus and nursing intervention

Authors:
- Zhifang Li
- Xianlian Lei
- Bing Xu
- Suyun Wang
- Tiantian Gao
- Hongmei Lv
View Affiliations

Affiliations: Emergency Department, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China, Department of Obstetrics and Gynecology, Jining Maternal and Child Health Family Planning Service Center, Jining, Shandong 272100, P.R. China, No. 1 Department of Neurology, Qingdao Central Hospital, Qingdao University, Qingdao, Shandong 266041, P.R. China, Emergency Ward, The People's Hospital of Zhangqiu Area, Jinan, Shandong 250200, P.R. China, Urology Department, The People's Hospital of Zhangqiu Area, Jinan, Shandong 250200, P.R. China
Published online on: October 1, 2020 https://doi.org/10.3892/etm.2020.9257
Article Number: 127

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the risk factors of diabetes peripheral neuropathy (DPN) in type 2 diabetes mellitus, and to propose corresponding nursing intervention measures to provide the basis for early diagnosis, treatment and prevention of DPN. A retrospective analysis was performed on 130 patients with type 2 diabetes mellitus (T2DM) in the communities surrounding our hospital from January 2017 to June 2018. They were divided into a DPN group (62 cases) and non‑DPN group (control group, 68 cases). First, a univariate analysis was performed. DPN or non‑DPN were used as dependent variables, and statistically significant parameters in univariate analysis were used as independent variables. Multivariate logistic regression analysis was included to analyze the peripheral nerves in type 2 diabetes mellitus. At the same time, the patients with DPN were given individualized comprehensive nursing intervention. Univariate analysis showed that body mass index (BMI), diabetes duration, smoking history, drinking history, family history of diabetes, fasting blood glucose (FBG), postprandial blood glucose (PBG), glycosylated hemoglobin (HbA1c), triglyceride (TG), high‑density lipoprotein cholesterol (HDL‑C), systolic blood pressure, 24‑h urine microalbumin excretion (24hmALB), glomerular filtration rate (GFR), serum creatinine in DPN group were significantly different from those in the control group (P<0.05). Logistic regression analysis showed that the duration of diabetes, PBG, glycosylated hemoglobin (HbA1c), HDL‑C, 24hmALB, and GFR were independent risk factors for DPN. The quality of life [Physiological function (PF), Role‑physical (RP), Role‑emotional (RE), General health (GH), Social function (SF), Mental health (MH), Bodily pain (BP), Vitality (VT)] in the DPN group was significantly improved after six months of individualized nursing intervention compared with that before intervention (P<0.05). In conclusion, the high risk factors of DPN should be identified as early as possible, to prevent and delay the occurrence and development of diabetes peripheral neuropathy, so as to improve the quality of life of these patients.

View Figures

View References

1	Ang L, Cowdin N, Mizokami-Stout K and Pop-Busui R: Update on the management of diabetic neuropathy. Diabetes Spectr. 31:224–233. 2018.PubMed/NCBI View Article : Google Scholar
2	Popkin BM: Nutrition transition and the global diabetes epidemic. Curr Diab Rep. 15(64)2015.PubMed/NCBI View Article : Google Scholar
3	Albers JW and Pop-Busui R: Diabetic neuropathy: Mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep. 14(473)2014.PubMed/NCBI View Article : Google Scholar
4	Hewston P and Deshpande N: Falls and balance impairments in older adults with Type 2 diabetes: Thinking beyond diabetic peripheral neuropathy. Can J Diabetes. 40:6–9. 2016.PubMed/NCBI View Article : Google Scholar
5	Themistocleous AC, Ramirez JD, Shillo PR, Lees JG, Selvarajah D, Orengo C, Tesfaye S, Rice AS and Bennett DL: The pain in neuropathy study (PiNS): A cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain. 157:1132–1145. 2016.PubMed/NCBI View Article : Google Scholar
6	Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM and Ziegler D: Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 40:136–154. 2017.PubMed/NCBI View Article : Google Scholar
7	Schillinger D, Grumbach K, Piette J, Wang F, Osmond D, Daher C, Palacios J, Sullivan GD and Bindman AB: Association of health literacy with diabetes outcomes. JAMA. 288:475–482. 2002.PubMed/NCBI View Article : Google Scholar
8	Callaghan BC, Little AA, Feldman EL and Hughes RA: Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 13(CD007543)2012.PubMed/NCBI View Article : Google Scholar
9	Miller CK, Edwards L, Kissling G and Sanville L: Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: Results from a randomized controlled trial. Prev Med. 34:252–259. 2002.PubMed/NCBI View Article : Google Scholar
10	Im S, Kim SR, Park JH, Kim YS and Park GY: Assessment of the medial dorsal cutaneous, dorsal sural, and medial plantar nerves in impaired glucose tolerance and diabetic patients with normal sural and superficial peroneal nerve responses. Diabetes Care. 35:834–839. 2012.PubMed/NCBI View Article : Google Scholar
11	Lu B, Yang Z, Wang M, Yang Z, Gong W, Yang Y, Wen J, Zhang Z, Zhao N, Zhu X, et al: High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract. 88:289–294. 2010.PubMed/NCBI View Article : Google Scholar
12	Liebreich T, Plotnikoff RC, Courneya KS and Boulé N: Diabetes NetPLAY: A physical activity website and linked email counselling randomized intervention for individuals with type 2 diabetes. Int J Behav Nutr Phys Act. 6(18)2009.PubMed/NCBI View Article : Google Scholar
13	Campolina AG and Ciconelli RM: SF-36 and the development of new assessment tools for quality of life. Acta Reumatol Port. 33:127–133. 2008.(In Portuguese). PubMed/NCBI
14	Qu GB, Wang LL, Tang X, Wu W and Sun YH: The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: An update systematic review and meta-analysis. J Clin Transl Endocrinol. 9:25–31. 2017.PubMed/NCBI View Article : Google Scholar
15	Javed S, Alam U and Malik RA: Burning through the pa in: Treatments for diabetic neuropathy. Diabetes Obes Metab. 17:1115–1125. 2015.PubMed/NCBI View Article : Google Scholar
16	Tesfaye S and Selvarajah D: Advances in the epidemiology, pathogenesis and management of diabetes peripheral neuropathy. Diabetes Metab Res Rev. 28:8–14. 2012.PubMed/NCBI View Article : Google Scholar
17	Djibril AM, Mossi EK, Djagadou AK, Balaka A, Tchamdja T and Moukaila R: Epidemiological, diagnostic, therapeutic and evolutionary features of diabetic foot: A study conducted at the medico-surgical clinic, University Hospital Sylvanus Olympio in Lomé. Pan Afr Med J 30: 4, 2018 (In French).
18	Veves A, Backonja M and Malik RA: Painful diabetic neuropathy: Epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 9:660–674. 2008.PubMed/NCBI View Article : Google Scholar
19	Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS and Cha BY: Prevalence and clinical implications of painful diabetes peripheral neuropathy in type 2 diabetes mellitus: Results from a nationwide hospital-based research of diabetes neuropathy in Korea. Diabetes Res Clin Pract. 103:522–529. 2014.PubMed/NCBI View Article : Google Scholar
20	Al-Mahroos F and Al-Roomi K: Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: A nationwide primary care diabetes clinic-based study. Ann Saudi Med. 27:25–31. 2007.PubMed/NCBI View Article : Google Scholar
21	Pai YW, Lin CH, Lee IT and Chang MH: Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes. Diabetes Metab. 44:129–134. 2018.PubMed/NCBI View Article : Google Scholar
22	Ziegler D, Strom A, Lobmann R, Reiners K, Rett K and Schnell O: High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study). J Diabetes Complications. 29:998–1002. 2015.PubMed/NCBI View Article : Google Scholar
23	Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MH and Matthews DR: The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr. 4(21)2012.PubMed/NCBI View Article : Google Scholar
24	McCarter RJ, Hempe JM and Chalew SA: Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: An analysis of data from the diabetes control and complications trial. Diabetes Care. 29:352–355. 2006.PubMed/NCBI View Article : Google Scholar
25	Li G, Sun C, Wang Y, Liu Y, Gang X, Gao Y, Li F, Xiao X and Wang G: A clinical and neuropathological study of Chinese patients with diabetic peripheral neuropathy. PLoS One. 9(e91772)2014.PubMed/NCBI View Article : Google Scholar
26	Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA and Feldman EL: Elevated triglycerides correlate with progression of diabetes neuropathy. Diabetes. 58:1634–1640. 2009.PubMed/NCBI View Article : Google Scholar
27	Padilla A, Descorbeth M, Almeyda AL, Payne K and De Leon M: Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity. Brain Res. 1370:64–79. 2011.PubMed/NCBI View Article : Google Scholar
28	Ikura K, Hanai K, Shinjyo T and Uchigata Y: HDL cholesterol as a predictor for the incidence of lower extremity amputation and wound-related death in patients with diabetic foot ulcers. Atherosclerosis. 239:465–469. 2015.PubMed/NCBI View Article : Google Scholar
29	Isak B, Oflazoglu B, Tanridag T, Yitmen I and Us O: Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev. 24:563–569. 2008.PubMed/NCBI View Article : Google Scholar
30	Hämäläinen H, Rönnemaa T, Halonen JP and Toikka T: Factors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: A population-based 7-year follow-up research. J Intern Med. 246:97–103. 1999.PubMed/NCBI View Article : Google Scholar
31	Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AAF and Feldman EL: Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 58:1634–1640. 2009.PubMed/NCBI View Article : Google Scholar
32	Li L, Chen J, Wang J and Cai D: Prevalence and risk factors of diabetic peripheral neuropathy in type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China. Prim Care Diabetes. 9:191–195. 2015.PubMed/NCBI View Article : Google Scholar
33	Davies B, Edwards N, Ploeg J and Virani T: Insights about the process and impact of implementing nursing guidelines on delivery of care in hospitals and community settings. BMC Health Serv Res. 8(29)2008.PubMed/NCBI View Article : Google Scholar